The role of DNA methylation in enhancing the sensitivity of colorectal cancer cells to topoisomerase inhibitors.

2015/17/N/NZ3/03737

Keywords

Descriptors

  • NZ3_1: Biologia komórki
  • NZ2_1: Genetyka molekularna
  • NZ5_7: Leczenie chorób człowieka

Panel

NZ3 – Cellular and developmental biology: cell biology, developmental biology, ageing biology, neurobiology

Host institution

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

Voivodeship: dolnośląskie

Other projects carried out by the institution »

Principal investigator (from the host institution)

Alicja Patrycja Pawlak

Number of co-investigators in the project: 2

Call

PRELUDIUM 9 – announced on 2015-03-16

Amount awarded
150 000 PLN
Project start date
2016-01-26
Project end date
2018-02-25
Project duration
25 months (the same as in the proposal)
Project status
Project settled

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Information in the final report

Publication in academic press/journals (1)

  1. Long-lasting reduction in clonogenic potential of colorectal cancer cells by sequential treatments with 5-azanucleosides and topoisomerase inhibitors.

    Authors:
    Alicja Pawlak, Ewa Ziolo, Anna Fiedorowicz, Klaudyna Fidyt, Leon Strzadala, Wojciech Kalas
    Academic press:
    BMC Cancer (year: 2016, volume: 1,28680555555556, pages: 46035), Publisher: BioMed Central
    Status:
    Published
    DOI:
    10.1186/s12885-016-2925-6 – link to the publication

« New search

Graphic design and implementation: Jakub Piotrowski